PT-141 (Bremelanotide)

Overview

PT-141 (Bremelanotide) is a medication that is used in the treatment of hypoactive sexual desire disorder (HSDD). It is manufactured as 10mg/vial injections which contain Bremelanotide 10mg and excipients.

Bremelanotide Mechanism of Action

Bremelanotide is a melanocortin Receptor agonist. It acts on M1 – M5 receptors to exert its effect which is to increase libido in the absence of underlying medical problems.

Bremelanotide Dosage

One injection before sexual activity.

Bremelanotide Side Effects

Nausea and vomiting, cough, injection site reactions, headache, cough.

Bremelanotide Interactions

COX inhibitors, Naltrexone.